Author Archive: Jim Greenwood

Jim Greenwood

Jim joined BIO as President & CEO in 2005 after representing the eighth district of Pennsylvania in the U.S. House of Representatives for six terms.  He had worked with BIO while in Congress on stem cell research and other health issues, and has since learned so much about the many applications of the science in food and agriculture and in industrial and environmental biotechnology.

Due to its revolutionary research and development in issues ranging from feeding the world by increasing crop yields to healing the world with new medicines to providing cleaner sources of energy, Jim is a passionate champion for biotechnology. When visiting member companies, he is inspired by executives and scientists who are united in their mission to help patients, farmers and other consumers lead a better life.

Prior to Congress, Jim served in the Pennsylvania House of Representatives and Pennsylvania Senate for six years each.  He and his wife Tina live in historic Washington Crossing, Pennsylvania (where he has participated in the re-enactment of George Washington crossing the Delaware River on Christmas Day in 1776). He enjoys fishing, birding and scuba diving.

You can find him on Facebook at https://www.facebook.com/jamescgreenwood.

Latest Posts

Time for AHIP to Finally Join Us And Work Toward A Solution

Greenwood_Jim_BTN

I worked as an elected leader in government for 24 years. One of the enduring lessons I learned is that to accomplish big things, people from different backgrounds must come together and unite behind a common solution. When that happens, our nation flourishes. And those problems that once seemed deep and complex, suddenly don’t seem so insurmountable anymore. That’s why it was so disappointing to hear America’s Health Insurance Plans’ (AHIP) ridiculous claim that my Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

ICER’s Flawed Methodology Could Lead To Healthcare Rationing

Greenwood_Jim_BTN

In a column published in USA Today recently, Jeff Stier, a Senior Fellow at the National Center for Public Policy Research, sheds light on the Institute for Clinical and Economic Review (ICER). Stier points out the group’s fundamentally-flawed (and possibly dangerous) approach and how their reports influence which drugs are listed on your insurer’s formulary based on what those drugs will cost the insurer – rather than what’s best for you as a patient.  “…we’ve Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

My Keynote Address at the 2016 BIO International Convention

Greenwood_Jim_BTN

Yesterday, the voters of California had their say. The general election is upon us. It’s Clinton vs. Trump. Fasten your seat belts, folks. This election is going to be fascinating, but it’s not going to be pretty. Today, we turn to politics, and more specifically, the intersection between politics and policy. In a few minutes, we’ll hear from three Washington veterans. They’ll preview a race for the White House that figures to be unlike anything Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Californians Must Reject Scare Tactics, Stand Together In Support Of Innovation

BIO_2016

This week, the BIO International Convention kicks off in San Francisco. As BIO’s President and CEO, I’m proud to bring this annual event to the Bay Area and talk about biopharmaceutical’s advances in innovation and bringing cures to those afflicted with disease. Before the campaign season arrives, it’s time to set the record straight about the value of prescription drugs and why insurance companies are demanding that you pay more out of pocket. Voters in Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

A Closer Look at AHIP’s Claims

new-bio-logo

This morning, in a letter to the editor of the New York Times, Marilyn Tavenner, President and CEO of America’s Health Insurance Plans (AHIP), attempted to lay the blame for higher healthcare costs and insurance premiums at the feet of America’s cutting-edge biopharma companies. AHIP has been peddling these falsehoods and misinformation for years.  Tavenner’s (and her organization’s) claims are—at best—uninformed. At worst, they are outright distortions deployed to hide the facts from patients who Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,